Colorectal Cancer

By joking about her cancer diagnosis, one survivor hopes to raise awareness and help people find laughter.

From radioactive remains to entertainment news, check out this week’s quick overview of what is making headlines in the cancer space.

The side effects of colorectal cancer and its treatment—which span beyond fertility issues—require constant renegotiation and reframing of what it means to be me.

Why use one term over the other? It's not about exclusion, but rather inclusion and reaching all at risk for this disease-- which happens to be everyone.

A daily dose of diet soda may help protect survivors of colon cancer from disease recurrence and death.

Your disease does not make you unworthy, because only the worthy will see past it.

I've had many outward signs that let the world know I had cancer, so the latest addition to my wardrobe didn't exactly make it much more obvious.

A geneticist I never met in person saved my life by insisting my gastroenterologist do a new colonoscopy. Had it not been for Mellissa Clarkson, I would have battled a new cancer that may have been discovered too late.

Here are the top 5 CURE stories for January 2019.

23andMe received Food and Drug Administration (FDA) clearance for a genetic health risk report on a hereditary colorectal cancer syndrome, according to the genetics company.

When bad things happen to friends we care about, we often stand in silence because we don't know what to say.

Here are the top 5 CURE stories for November 2018.

I would tune out or give an unsympathetic nod when I would hear people talk about anxiety because I didn't understand what it really was or how paralyzing it could be. That was until I got cancer.

An aspirin a day may help keep colorectal cancer at bay, according to recent research.

My son was visibly proud to show me off to his class that day, and I was secretly proud to send his classmates home to talk about poop at the dinner table.

A new American Cancer Society guideline recommends starting screening for colorectal cancer at age 45.

When I was diagnosed with Lynch syndrome seven years ago, I began blogging about the roller coaster of emotions I experienced after undergoing genetic testing and prophylactic surgeries.

A high dose of precision radiation could drastically increase the survival rates of patients with metastatic cancer, and double the time patients live without cancer growth, according to study results presented at the 60th Annual Meeting of the American Society for Radiation Oncology.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Immunotherapy pioneers James P. Allison and Dr. Tasuku Honjo have won the 2018 Nobel Prize in Physiology or Medicine for their research that eventually led to the use of immune checkpoint inhibitors to treat cancer.

Getting a third opinion probably didn't save my life, but it definitely bought me more time.

Tumor testing can lead to different treatment choices and better outcomes.

As a parent facing cancer, we just want to know that our children will emerge on the other side of our diagnosis and be alright.

The FDA has granted a breakthrough therapy designation to the combination of the BRAF inhibitor Braftovi (encorafenib), the MEK inhibitor Mektovi (binimetinib), and the EGFR inhibitor Erbitux (cetuximab) for the treatment of patients with BRAF V600E–mutant metastatic colorectal cancer (mCRC) following one or two prior lines of treatment in the metastatic setting.

Scientists have spent 35 years seeking ways to disable RAS, a gene that’s mutated in many cancer types. Now, they’re moving closer to solutions.

The FDA approved Opdivo plus Yervoy to treat a certain subset of patients with metastatic colorectal cancer.

The American Cancer Society issued an updated guideline recommendation that now calls for screening to begin at age 45 for individuals at average risk for colorectal cancer.

Understanding one’s biomarkers, such as microsatellite stable (MSS) or instable (MSI) status in tumors, is key in understanding how a patient with colorectal cancer may be treated.

Take a look at the top five CURE stories of June 2018 in this video.